Notice: The package picture above is not ultimate, only for reference
Compare with DA0930，the DA0992 can shorten the PCR time by half by applying FastTaq Polymerase, and also compatible with the magnetic bead nucleic acid extraction kit or spin column nucleic acid extraction kit. With ABI7500,the PCR time would be shortened to 62 mins, and with AGS4800, the PCR time would be shortened to 50 mins. The UDG(UNG) enzyme would decrease the threat of the PCR product aerosol pollution, to ensure the PCR laboratory's normal running.
Catalog Number: DA0990~DA0995
ORF1ab and N gene
RNase P as internal control
Ct cut-off: ≤30
Throat swab or sputum
UDG enzyme to anti-pollution
This kit can also compatible with ABI7500,BIO-RAD CFX96, AGS4800, AGS8830, lightCycler 480
Faster than ever, shorten 50% of testing time
UDG enzyme, whose mechanism of action is to selectively hydrolyze and break the uracil glycosidic bond in double-stranded or single-stranded DNA containing dU to form the DNA chains with missing bases, which would be further hydrolyzed and broken under alkaline media and high temperature, thus being eliminated.
Detection Kit for 2019-nCoV (PCR-Fluorescence) is used for the in vitro qualitative detection of novel coronavirus (2019-nCoV) ORF1ab and N gene in the throat swabs, sputum, nasopharyngeal swab specimens of suspected pneumonia patients infected by novel coronavirus, suspected clustering cases, and others needing a diagnosis or differential diagnosis for novel coronavirus.
Certificates for kits：
Detection Kit for 2019-nCoV (PCR-Fluorescence), the DA0992 has been approved by NMPA, FSC and CE.
Simulated virus ( pseudovirus )to ensure quality：
The positive control and negative control of the kit are simulated RNA virus particles, which are similar to the virus structure, and they are coated with protein as well, join the extraction step parallelly, which is easier to monitor the entire experimental process and ensure the reliability of the test results.
Warning and Precautions：
For the definitions of "suspected cases" and "suspected clustering cases", refer to the documents (current versions) such as Diagnosis and Treatment Scheme for Pneumonia Patients Infected by Novel Coronavirus and Monitoring Scheme for Pneumonia Patients Infected by Novel Coronavirus issued by the Chinese Center for Disease Control and Prevention (China CDC).
This product is only used for the auxiliary diagnosis and in vitro diagnosis (IVD) of pneumonia infected by novel coronavirus (2019-nCoV) since December 2019 under emergency. Instead, it cannot be clinically used as a general IVD reagent. In use, the relevant requirements of the documents such as Diagnosis and Treatment Scheme for Pneumonia Patients Infected by Novel Coronavirus and Monitoring Scheme for Pneumonia Patients Infected by Novel Coronavirus shall be followed.
Detection of novel coronavirus RNA shall meet the requirements of the Technical Guideline of the China CDC for Laboratory Detection of New Coronavirus Pneumonia and other documents, so as to carry out the regulations on biosafety. The detection results of this kit are for clinical reference only and should not be used as the sole criteria for clinical diagnosis. It is recommended to conduct a comprehensive analysis of the condition in combination with the clinical manifestations of the patient and other laboratory tests.
Detection Kit for 2019-nCoV (PCR-Fluorescence)